 Akero Therapeutics Inc NASDAQ: AKRO announced a 25 million equity investment by Pfizer Inc NYSE: PFE at 9.90 per share. The company also announced a term loan facility providing Akero with access to up to 100 million from Hercules Capital Inc NYSE:. 